Simris Biologics is focused on identifying and developing applications for novel, natural biologics sourced from cyanobacteria and microalgae. The company develops technology platforms based on these compounds and collaborates with customers under license agreements to create final products.

Simris Biologics

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Google Font API

Microsoft Exchange Online

Apache

Office 365 Mail

Microsoft Azure DNS

AJAX Libraries API

Heike Enke

Co-Founder & Chief Scientific Officer

Chief Science Officer

Dan Enke

Chief Scientific Officer

Europe, Middle East, and Africa (EMEA) Biopharma Companies

Berlin Companies With Less Than $1B in Revenue

Berlin Companies (Top 10K)

City of Berlin Companies With Fewer Than 100 Employees (Top 10K)

Simris Biologics is a wholly-owned subsidiary of the Simris Group. Within Simris Biologics they hold a library of over 1,200 strains of cyanobacteria producing over 5,000 novel compounds. Initial screening has revealed compounds with potential application as pesticides, herbicides, fungicides, insecticides, and plant growth stimulants as well as novel antibiotics, new toxins within biopharma and antioxidants and UV-protectors for skin care.

Berlin

Germany

Europe

Simris Biologics signs Material Transfer Agreement with pre-clinical biotech company to develop Linker-Payloads

India

Asia

The Netherlands

Simris Biologics identifies and develops applications for novel, natural biologics sourced from cyanobacteria and microalgae. The company develops technology platforms based on these compounds and partners with customers to create final products.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 5:11 PM	5e55cd40
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 5:11 PM	09402dc1
crunchbase trigger	general	Nov 12, 2024 5:11 PM	90dc3647
crunchbase profile	general	Nov 13, 2024 3:52 PM	1ea37b9f
li profile	general	Nov 12, 2024 5:11 PM	94eb26b6
translate crunchbase fundingrounds	general	Nov 13, 2024 4:21 PM	59af31b5
peers	general	Nov 12, 2024 5:11 PM	241e4580
news basic	general	Nov 12, 2024 5:11 PM	ba136a3c
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

SIMR

COM:SIMRISBIOLOGICS

Simris Biologics